Ebrahimpour-Koujan et al. designed an ongoing randomized clinical trial aiming to determine the impact of vitamin D supplementation on VDR serum levels, and fibrogenic miRNAs (miR-21, miR-34, and miR-122) in patients with MASH [142]. This evidence concerns the gene VDR and metabolic dysfunction-associated steatohepatitis.